

"Real-time disease forecasting and predictive health intelligence for global decision makers."
Airfinity tracks, simulates and predicts population level disease outcomes in real time. The company provides health intelligence that helps governments, pharmaceutical companies and healthcare organisations make faster decisions during disease outbreaks and public health challenges. Its platform integrates global data to forecast disease trajectories and evaluate medical countermeasures. Used by the White House, UK Government, WHO and pharmaceutical leaders, Airfinity delivers predictive models that inform resource allocation, investment and policy decisions. Specialising in infectious diseases and cardiovascular conditions, the company provides decision makers with answers in hours rather than months to improve health outcomes worldwide.


120
Team Members
2015
Founded
Consulting
Sector
Hybrid
Work Environment
A world where health threats are anticipated before they escalate, where every population has equal access to life-saving interventions, and where data-driven foresight prevents disease from limiting human potential.
Airfinity's mission is to invent a radically better way to structure, assess and share new science to inform decisions that can increase the global life span.